ACAN and arthritic joint disease: The development of inhibitors for ADAMTS proteases is primarily focused on inhibiting ADAMTS4 and ADAMTS5 due to their prominent role in cartilage destruction in arthritis where both proteases degrade aggrecan, a major structural proteoglycan in the articular cartilage (Verma and Dalal, 2011).